SAM
TSVT

Shell Asset Management’s 2seventy bio TSVT Stock Holding History

Shell Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-44,436
Closed -$174K – 1279
2023
Q3 		$174K Buy
44,436
+39,898
+879% +$262K 0.01% 950
2023
Q2 		$46K Sell
4,538
-24
-0.5% -$254 ﹤0.01% 1220
2023
Q1 		$47K Sell
4,562
-17
-0.4% -$194 ﹤0.01% 1192
2022
Q4 		$43K Sell
4,579
-561
-11% -$7.91K ﹤0.01% 1277
2022
Q3 		$75K Sell
5,140
-667
-11% -$9.9K ﹤0.01% 1289
2022
Q2 		$77K Buy
5,807
+83
+1% +$1.13K ﹤0.01% 1322
2022
Q1 		$98K Sell
5,724
-842
-13% -$14.3K ﹤0.01% 1298
2021
Q4 		$168K Buy
+6,566
New +$205K ﹤0.01% 1249

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Shell Asset Management's TSVT Position: Q4 2023 in Review

Shell Asset Management sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 44,436 shares — an estimated $174K sold.

Shell Asset Management first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $174K in Q3 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Shell Asset Management reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Shell Asset Management sold 44,436 2seventy bio shares in Q4 2023, an estimated $174K.
  • Shell Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • Shell Asset Management's 2seventy bio position peaked at $174K in Q3 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Shell Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.